Michael McGowan
Senior Director of Market Intelligence

About

Michael McGowan is Senior Director of Market Intelligence at SHL Medical, responsible for the research and analysis of market trends and business strategies. Mr McGowan has over 20 years of experience in the medical industry with a focus on the international sales and marketing management of injectables and drug delivery devices.

Contributions

INJECTION

ENABLING LARGE-VOLUME, HIGH-DOSE SUBCUTANEOUS AUTOINJECTIONS WITH CARTRIDGE-BASED TECHNOLOGIES

Michael McGowan, examines the emerging interest in autoinjectors that are capable of delivering higher injection volumes into the subcutaneous space and considers the potential benefits of SHL Medical’s cartridge-based 3 and 5 mL Maggie^® autoinjectors.

More contributions

INJECTION

30 YEARS IN THE MAKING – AN INSIDE PERSPECTIVE ON THE EMERGENCE OF AUTOINJECTORS

Michael McGowan, Director of Market Intelligence at SHL Group, gives a perspective on the emergence of the autoinjector as a key component of the drug delivery industry, in the context of SHL celebrating its 30th anniversary this year – a journey of rapid development that reflects the growing demand for advanced drug delivery systems in the healthcare market.

PREFILLED SYRINGES

VOICE OF CUSTOMER RESEARCH – A CUSTOMER-CENTRIC APPROACH TO STRATEGY DEVELOPMENT

Michael McGowan discusses SHL’s view on adapting to the shifts in market needs and stakeholder priorities in the pharma and biotech sectors, and details how SHL has implemented a “voice of customer” market research programme to ensure it provides the best possible service for its customers.